本页面由Tiger Trade Technology Pte. Ltd.提供服务

FibroBiologics

1.00
-0.1300-11.50%
盘后:1.010.0100+1.00%19:48 EDT
成交量:15.20万
成交额:15.61万
市值:665.82万
市盈率:-0.21
高:1.14
开:1.12
低:0.9893
收:1.13
52周最高:9.99
52周最低:0.6201
股本:665.82万
流通股本:554.46万
量比:0.96
换手率:2.74%
股息:- -
股息率:- -
每股收益(TTM):-4.7656
每股收益(LYR):-8.3501
净资产收益率:-660.08%
总资产收益率:-95.77%
市净率:1.44
市盈率(LYR):-0.12

数据加载中...

2024/08/27

重要事件披露

Form 8-K - Current report
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/27

重要事件披露

Form 8-K - Current report
2024/06/22

SEC问询函

Form CORRESP - Correspondence
2024/06/22

SEC问询函

Form CORRESP - Correspondence
2024/06/19

SEC问询函

Form CORRESP - Correspondence
2024/06/18

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/04

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/26

重要事件披露

Form 8-K - Current report
2024/04/26

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/28

SEC问询函

Form CORRESP - Correspondence
2024/03/27

SEC问询函

Form CORRESP - Correspondence
2024/03/26

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/16

SEC问询函

Form CORRESP - Correspondence
2024/03/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/20

重要事件披露

Form 8-K - Current report